US Stock MarketDetailed Quotes

BYSI BeyondSpring

Watchlist
  • 1.910
  • +0.110+6.11%
Close Apr 19 16:00 ET
74.52MMarket Cap-2690P/E (TTM)

About BeyondSpring Company

BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in New York, NY.

Company Profile

SymbolBYSI
Company NameBeyondSpring
Listing DateMar 9, 2017
Issue Price20.00
Founded2014
CEODr. Lan Huang, PhD
MarketNASDAQ
Employees67
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address28 Liberty Street,39th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10005
Phone1-646-305-6387
Websitehttp://www.beyondspringpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lan Huang, PhD
  • Chairman of the Board and Chief Executive Officer
  • --
  • Dr. Sihai Xu, M.B.A.
  • Director
  • --
  • Matthew Kirkby
  • Independent Director
  • --
  • Patrick Fabbio
  • Independent Director
  • --
  • Brendan Delaney
  • Independent Director
  • --
  • Dr. Jiangwen Majeti, M.B.A.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg